Consumers who purchased Zicam cold remedy products before October 17, 2024, may be eligible for a cash payment as part of a $6 million class action settlement. The lawsuit alleged that Zicam falsely advertised its products as being able to shorten the duration and lessen the severity of colds, misleading customers into purchasing them under Continue reading